JP2008545752A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545752A5 JP2008545752A5 JP2008514854A JP2008514854A JP2008545752A5 JP 2008545752 A5 JP2008545752 A5 JP 2008545752A5 JP 2008514854 A JP2008514854 A JP 2008514854A JP 2008514854 A JP2008514854 A JP 2008514854A JP 2008545752 A5 JP2008545752 A5 JP 2008545752A5
- Authority
- JP
- Japan
- Prior art keywords
- igf
- subject
- growth hormone
- growth
- protein according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68761705P | 2005-06-02 | 2005-06-02 | |
| PCT/US2006/021282 WO2006130769A2 (en) | 2005-06-02 | 2006-06-01 | Methods for treatment of growth disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014043298A Division JP2014129405A (ja) | 2005-06-02 | 2014-03-05 | 成長障害を処置するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545752A JP2008545752A (ja) | 2008-12-18 |
| JP2008545752A5 true JP2008545752A5 (enExample) | 2009-08-20 |
Family
ID=37482318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514854A Pending JP2008545752A (ja) | 2005-06-02 | 2006-06-01 | 成長障害を処置するための方法 |
| JP2014043298A Pending JP2014129405A (ja) | 2005-06-02 | 2014-03-05 | 成長障害を処置するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014043298A Pending JP2014129405A (ja) | 2005-06-02 | 2014-03-05 | 成長障害を処置するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8158582B2 (enExample) |
| EP (1) | EP1901770B1 (enExample) |
| JP (2) | JP2008545752A (enExample) |
| ES (1) | ES2532089T3 (enExample) |
| WO (1) | WO2006130769A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2689549A1 (en) | 2007-06-08 | 2008-12-18 | Massachusetts Institute Of Technology | Igf for the treatment of rett syndrome and synaptic disorders |
| US8759299B2 (en) | 2009-07-22 | 2014-06-24 | Ipsen Pharma S.A.S. | Analogues of insulin-like growth factor-1 (IGF-1) having amino acid substitution at position 59 |
| CA2780554C (en) * | 2009-11-17 | 2017-08-15 | Ipsen Pharma S.A.S. | Formulation for hgh and rhigf-1 combination |
| EP3597178A1 (en) * | 2012-06-21 | 2020-01-22 | Phosphorex Inc. | Nanoparticles of indirubin, derivatives thereof and methods of making and using same |
| WO2016100528A1 (en) * | 2014-12-16 | 2016-06-23 | Puretein Bioscience Llc. | Methods for increasing serum igf-1 in an animal |
| KR20250025051A (ko) * | 2017-08-24 | 2025-02-20 | 사노피 | 산성 스핑고미엘린분해효소 결핍증 환자에서의 비정상적 골병태의 치료 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374620A (en) | 1990-06-07 | 1994-12-20 | Genentech, Inc. | Growth-promoting composition and its use |
| US5126324A (en) | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
| US5681814A (en) | 1990-06-07 | 1997-10-28 | Genentech, Inc. | Formulated IGF-I Composition |
| SE9002731D0 (sv) | 1990-08-24 | 1990-08-24 | Kabivitrum Ab | Product comprising growth factor |
| TW267102B (enExample) | 1992-03-13 | 1996-01-01 | Ciba Geigy | |
| IL106546A0 (en) | 1993-08-01 | 1993-12-08 | Zvi Rozenberg | Apparatus for a bicycle and a two wheel vehicle |
| US5824642A (en) * | 1994-04-07 | 1998-10-20 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
| US5646113A (en) * | 1994-04-07 | 1997-07-08 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
| US5741776A (en) | 1995-05-22 | 1998-04-21 | Genentech, Inc. | Method of administration of IGF-I |
| ATE536186T1 (de) * | 2003-09-12 | 2011-12-15 | Tercica Inc | Verfahren zur behandlung von igf-1 (insulin-like growth factor 1)-mangel |
| CA2780554C (en) | 2009-11-17 | 2017-08-15 | Ipsen Pharma S.A.S. | Formulation for hgh and rhigf-1 combination |
-
2006
- 2006-06-01 WO PCT/US2006/021282 patent/WO2006130769A2/en not_active Ceased
- 2006-06-01 EP EP06784529.7A patent/EP1901770B1/en not_active Not-in-force
- 2006-06-01 US US11/915,978 patent/US8158582B2/en not_active Expired - Fee Related
- 2006-06-01 ES ES06784529.7T patent/ES2532089T3/es active Active
- 2006-06-01 JP JP2008514854A patent/JP2008545752A/ja active Pending
-
2012
- 2012-03-12 US US13/417,983 patent/US8440616B2/en not_active Expired - Fee Related
-
2014
- 2014-03-05 JP JP2014043298A patent/JP2014129405A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2653201A1 (en) | Compositions and uses of e3-gp19k for treating diabetes | |
| Klepstad et al. | Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post‐herpetic neuralgia | |
| Lau et al. | Impact of current and emerging glucose-lowering drugs on body weight in type 2 diabetes | |
| PT762890E (pt) | Tratamento de diabetes | |
| JP2002517468A (ja) | 機能性消化不良および／または過敏性腸症候群の治療用の医薬組成物ならびにその中の物質の新規な使用 | |
| US20090054372A1 (en) | Combination therapy for weight loss | |
| JP2010502639A (ja) | Ｈｇｈを含む経口送達用医薬組成物 | |
| TWI748945B (zh) | 第２型糖尿病病患治療 | |
| Page-Wilson et al. | Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery | |
| Greenway et al. | Treatment of hypothalamic obesity with caffeine and ephedrine | |
| Newshan et al. | Palliative care: pain and symptom management in persons with HIV/AIDS | |
| JP2020536854A (ja) | 医学療法におけるセマグルチド | |
| CN117355297A (zh) | 用于诱导褐色脂肪生成的方法和组合物 | |
| RU2007101695A (ru) | Лекарственный препарат для лечения сахарного диабета на основе экзенатида и даларгина, применение и способ лечения | |
| JP2014129405A5 (enExample) | ||
| Zavatta et al. | Challenges in the management of chronic hypoparathyroidism | |
| JP2008545752A5 (enExample) | ||
| KR20090019896A (ko) | 도파민 또는 성장 호르몬 수용체 길항제와의 소마토스타틴-유사체의 조합물 | |
| BR112020018362A2 (pt) | Composição de glp-1 para tratar obesidade e controle de peso | |
| JP2023510609A (ja) | Ｇｌｐ－１および／またはｇｌｐ－１類似体、ならびにインスリンおよび／またはインスリン類似体を含む併用療法 | |
| Cook | Growth hormone and estrogen: a clinician's approach | |
| US8614184B2 (en) | HCG formulations for achieving weight loss | |
| Carvalho et al. | Acromegalic features in growth hormore (GH)‐deficient patients after long‐term GH therapy | |
| WO2024042518A1 (en) | Glp-1 receptor antagonist and methods of use thereof | |
| Aviv et al. | Patterns of local site reactions to subcutaneous glatiramer acetate treatment of multiple sclerosis: a clinicopathological study |